Impact of metagenomic next-generation sequencing on clinical decision-making at an academic medical center, a retrospective study, Iowa, 2020-2022

Authors

Michael Olthoff, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
Takaaki Kobayashi, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
Meredith G. Parsons, Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
Bradley Ford, Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
Kunatum Prasidthrathsint, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.

Document Type

Article

Publication Date

1-1-2024

Journal Title

Antimicrobial stewardship & healthcare epidemiology : ASHE

Abstract

We assessed the impact of metagenomic next-generation sequencing (mNGS) on patient care using previously established criteria. Among 37 patients receiving mNGS testing, 16% showed results that had a positive clinical impact. While mNGS results may offer valuable supplementary information, results should be interpreted within the broader clinical context and evaluation.

First Page

e39

Recommended Citation

Olthoff, Michael; Kobayashi, Takaaki; Parsons, Meredith G.; Ford, Bradley; and Prasidthrathsint, Kunatum, "Impact of metagenomic next-generation sequencing on clinical decision-making at an academic medical center, a retrospective study, Iowa, 2020-2022" (2024). MaineHealth Maine Medical Center. 3657.
https://knowledgeconnection.mainehealth.org/mmc/3657